切除的IA期非小细胞肺癌中纤维化间质性肺异常对生存的影响
回顾性分析2010至2015年228例病理IA期NSCLC切除患者,术前高分辨率CT评估ILAs。纤维化ILAs患者16例(7.02%),其病因特异性死亡率显著高于无ILAs者,术后5年生存率61.88% vs 93.03%(p<0.001)。纤维化ILAs为病因特异性死亡的独立危险因素(调整HR=3.22,95%CI 1.10-9.44,p=0.033)。
要点
- 术前CT发现纤维化ILAs的IA期NSCLC切除患者5年生存率仅61.88%,显著低于无ILAs者的93.03%。
- 纤维化ILAs是病因特异性死亡的独立危险因素(调整HR=3.22,95%CI 1.10-9.44)。
- 放射科医生应熟悉ILAs概念,报告时关注纤维化ILAs以提示预后。
核心结论
- 在切除的病理IA期NSCLC患者中,纤维化ILAs的存在是病因特异性死亡的危险因素,纤维化ILAs患者术后5年生存率显著低于无ILAs者。
研究设计与样本
- 回顾性分析2010至2015年间接受根治性切除的病理IA期NSCLC患者228例(年龄63.27±8.54岁,男性133例[58.3%]),术前高分辨率CT评估ILAs,采用Kaplan-Meier分析和log-rank检验评估ILAs与病因特异性死亡的关系,Cox比例风险回归确定危险因素。
关键影像表现/征象
- 术前高分辨率CT检出ILAs者24例(10.53%),其中纤维化ILAs 16例(7.02%)。
- 纤维化ILAs患者病因特异性死亡率显著高于无ILAs者(p<0.001)。
- 术后5年生存率纤维化ILAs患者为61.88%,无ILAs者为93.03%(p<0.001)。
诊断标准与关键数值
- 纤维化ILAs为病因特异性死亡的独立危险因素:调整后风险比=3.22(95%CI 1.10-9.44,p=0.033)。
临床应用与阅片要点
- 放射科医生和临床医生应熟悉相对较新的ILAs概念,理解ILA状态与切除IA期NSCLC长期生存的密切关联。
- 作者认为,表现为纤维化ILAs的患者应接受适当的监测和管理以优化预后。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the association between fibrotic interstitial lung abnormalities (ILAs) and long-term survival in patients with resected Stage IA non-small cell lung cancer (NSCLC).
METHODS: Data of patients who underwent curative resection of pathological Stage IA NSCLC between 2010 and 2015 were retrospectively analysed. ILAs were evaluated using pre-operative high-resolution CT scans. The association between ILAs and cause-specific mortality was assessed via Kaplan-Meier analysis and the log-rank test. Cox proportional hazards regression was performed to determine the risk factors for cause-specific death.
RESULTS: Overall, 228 patients were identified (63.27 ± 8.54 years, 133 men [58.3%]). ILAs were detected in 24 patients (10.53%). Fibrotic ILAs were observed in 16 patients (7.02%), and there was a significantly higher cause-specific mortality rate among patients with fibrotic ILAs compared with patients with no ILAs (p < 0.001). Patients with fibrotic ILAs had a significantly higher cause-specific mortality rate than patients without ILAs at 5 post-operative years (survival rate: 61.88% vs 93.03%, p < 0.001). The presence of afibrotic ILA was an independent risk factor for cause-specific death (adjusted hazard ratio = 3.22; 95% confidence interval: 1.10, 9.44; p = 0.033).
CONCLUSION: The presence of afibrotic ILA was a risk factor for cause-specific death in patients with resected Stage IA NSCLC. Radiologists and clinicians should be familiar with the relatively new concept of ILAs and understand the close association between ILA status and long-term survival in resected Stage IA NSCLC. Patients presenting fibrotic ILAs should receive appropriate surveillance and management to optimise prognosis.
ADVANCES IN KNOWLEDGE: Fibrotic ILAs are important findings implicated inthe long-term survival of patients with resected Stage IA NSCLC. Specific management is required for this group.
引用
- Jeong, Kim. Survival impact of fibrotic interstitial lung abnormalities in resected stage IA non-small cell lung cancer. Br J Radiol. 2023. PMID: 37191186. doi:10.1259/bjr.20220812
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。